Plasma IgA as a biomarker and IL-21 as a potential therapeutic target in Inflammatory Bowel Disease

被引：0
|
作者：
Tsai, T. [1 ,2 ,3 ]
Hsu, J. L. [4 ,5 ]
机构：
[1] China Med Univ Hosp, Ctr Digest Med, Taichung, Taiwan
[2] Natl Hlth Res Inst, Immunol Res Ctr, Miaoli, Taiwan
[3] China Med Univ, Sch Med, Taichung, Taiwan
[4] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan
[5] China Med Univ, Drug Dev Ctr, Taichung, Taiwan
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0633
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0459
引用
收藏
页码：I981 / I982
页数：2
相关论文
共 50 条
  • [31] Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease
    Guo, Xue
    Huang, Chen
    Xu, Jing
    Xu, Haoming
    Liu, Le
    Zhao, Hailan
    Wang, Jiaqi
    Huang, Wenqi
    Peng, Wu
    Chen, Ye
    Nie, Yuqiang
    Zhou, Yongjian
    Zhou, Youlian
    FRONTIERS IN NUTRITION, 2022, 8
  • [32] Microecology as a target for therapeutic intervention in inflammatory bowel disease
    Guarner, F
    IDRUGS, 2003, 6 (09) : 868 - 873
  • [33] Lymphangiogenesis in Inflammatory Bowel Disease; A New Therapeutic Target?
    Koutroubakis, Ioannis E.
    Binion, David G.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7
  • [34] Urinary chemerin as a potential biomarker for inflammatory bowel disease
    Gunawan, Stefan
    Elger, Tanja
    Loibl, Johanna
    Fererberger, Tanja
    Sommersberger, Stefanie
    Kandulski, Arne
    Mueller, Martina
    Tews, Hauke Christian
    Buechler, Christa
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] Abdominal pain as a therapeutic target in inflammatory bowel disease
    Hodgson, HJF
    TARGETS OF TREATMENT IN CHRONIC INFLAMMATORY BOWEL DISEASES, 2003, 131 : 188 - 192
  • [36] The intestinal microvasculature as a therapeutic target in inflammatory bowel disease
    Hatoum, Ossama A.
    Heidemann, Jan
    Binion, David G.
    INFLAMMATORY BOWEL DISEASE: GENETICS, BARRIER FUNCTION, IMMUNOLOGIC MECHANISMS, AND MICROBIAL PATHWAYS, 2006, 1072 : 78 - 97
  • [37] Salivary calprotectin: a potential biomarker in inflammatory bowel disease?
    Rodrigues, C.
    Gomes, A.
    Leal, J.
    Mendes, K.
    Correia, M. J.
    Pereira, P.
    Martins, R.
    Nelio, V.
    Rosa, N.
    Soares, C.
    Ministro, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I429 - I430
  • [38] Nitric oxide as a potential biomarker in inflammatory bowel disease
    Avdagic, Nesina
    Zaciragic, Asija
    Babic, Nermina
    Hukic, Mirsada
    Seremet, Mensura
    Lepara, Orhan
    Nakas-Icindic, Emma
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2013, 13 (01) : 5 - 9
  • [39] IL-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients
    Ozturk, Nilufer Aylin Acet
    Ursavas, Ahmet
    Dilektasli, Asli Gorek
    Demirdogen, Ezgi
    Coskun, Funda
    Ediger, Dane
    Uzaslan, Esra
    Yoyen-Ermis, Digdem
    Karaca, Mert
    Terzi, Orkun
    Bayram, Merve
    Omer, Dilara
    Yigitliler, Busra
    Yurttas, Ahmet
    Maharramov, Shahriyar
    Celik, Gamze
    Oral, Barbaros
    Karadag, Mehmet
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [40] IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials
    Koh, Choong-Hyun
    Kim, Byung-Seok
    Kang, Chang-Yuil
    Chung, Yeonseok
    Seo, Hyungseok
    IMMUNE NETWORK, 2024, 24 (01)
12345